biologic knee replacement presentation

119
Biologic Knee Replacement Kevin R. Stone, MD Ann W. Walgenbach, RNNP Wendy S. Adelson, MS Jonathan R. Pelsis, MHS Meniskus – Ersatz: Collagen Meniskus & Allograft 15. Janur 2010 Stone Research Foundation San Francisco

Upload: sfkneerobot

Post on 02-Nov-2014

9 views

Category:

Health & Medicine


1 download

DESCRIPTION

Biologic Knee Replacement (BKR) is our approach to treating knee injuries, from trauma to arthritis, and is designed to help people delay, or even avoid, artificial knee replacement. BKR is a scientifically-proven collection of our out-patient surgical techniques and procedures and consists of any combination of meniscus transplantation, articular cartilage paste grafting, ligament replacement as explained in further detail below. Being "bone on bone" does not always mean that the joint needs to be artificially replaced, often the "bone on bone" is isolated to a portion of the knee joint and this can be repaired using Biologic Knee Replacement.

TRANSCRIPT

Page 1: Biologic Knee Replacement Presentation

Biologic Knee Replacement

Kevin R. Stone, MDAnn W. Walgenbach, RNNP

Wendy S. Adelson, MSJonathan R. Pelsis, MHS

Meniskus – Ersatz:Collagen Meniskus & Allograft15. Janur 2010 Stone Research Foundation

San Francisco

Page 2: Biologic Knee Replacement Presentation

The Aging Knee

Pediatric Normal Adult OA Adult

Page 3: Biologic Knee Replacement Presentation

The Knee Joint

Page 4: Biologic Knee Replacement Presentation

Meniscus

• Key shock absorber in the knee

• Torn 1.5M times annually US

• Minimal healing– No spontaneous

regeneration template

Page 5: Biologic Knee Replacement Presentation

• Loss of meniscus cartilage leads to:• Increased forces across the knee joint• Increased risk of articular cartilage damage• Pain and arthritis in many cases

• Painful arthritic joints:• Rough surfaces• Harsh, degradative environment

The Problem

Page 6: Biologic Knee Replacement Presentation

• Reduce pain and improve function

• Preserve the biology of the knee

• Restore a biomechanically favorable environment

• Provide a buffer to prevent bone-on-bone contact and pain

The Goal

Page 7: Biologic Knee Replacement Presentation

The Alignment Controversy

• Is osteotomy a two plane crude correctionof a multiplanar deformed geometry?

• Is osteotomy really a correction?

• Are the complications worth it?

“Bad biomechanics ruins good biology any day of the week…”

…However, biology lasts decades even in mechanically disadvantaged knees.

Page 8: Biologic Knee Replacement Presentation

A Solution ?Biologic Knee Replacement

1. Smooth, repair, replace, or regenerate damaged articular cartilage

2. Meniscus reconstruction

3. Meniscus allograft transplantation

Fibrous interpostional joint arthroplasty

• Reduce pain and improve function

• Increase success of cartilage grafts

Page 9: Biologic Knee Replacement Presentation

Outerbridge Grading System

For Cartilaginous Degeneration

Grade I Soft discolored superficial fibrillation

Grade II Fragmentation < 1.3 cm 2

Grade III Fragmentation > 1.3 cm 2

Grade IV Erosion to subchondral bone (eburnation)

Outerbridge RE. The etiology of chondromalacia patellae. J Bone Joint Surg Br, 1961;43: 752-7.

Page 10: Biologic Knee Replacement Presentation

Meniscus Allograft Transplantation: Indications?

Traditional thought: Meniscus Transplantation does not work in arthritic knees (Noyes & Barber-Westin 1995, Stollsteimer 2000, Rath 2001)

Current thought: Meniscus Transplantation does work in arthritic knees if damaged articular cartilage is treated as well (van Arkel 2002, Noyes 2004, Verdonk 2005, Cole 2006, Stone 2006, Farr 2007, Rue 2008)

Page 11: Biologic Knee Replacement Presentation

Sizing: Surgeon Concerns

• “It takes me 6 months to get a properly sized meniscus.”

• “My measurements do not match the bank’s measurements.”

• “Is there an easier, more accurate method for sizing?”

Page 12: Biologic Knee Replacement Presentation

Meniscus Allograft: Sizing

• Success rate may be dependant on accurate sizing

• Image-based sizing measures bony landmarks and insertion points however: • Contrast limitations

• Identification of soft versus mineralized tissue interface

• Magnification errors

Schaffer B, Kennedy S, Flimkiewicz J, Yao L. Preoperative Sizing of the Meniscal Allografts in Meniscal transplantation. Am Journal of Sports Med. Vol. 28, No. 4, 2000.

Page 13: Biologic Knee Replacement Presentation

Supporting Studies: Sizing

• 148 heights and weights compared to MRI meniscus size

Pearson’s Correlations (r):

Height vs Total Tibial Plateau (TTP) r = 0.7194

Weight vs TTP r = 0.5470

TTP vs Medial and Lateral Meniscal Width r = 0.7386, r = 0.7209

TTP vs Medial and Lateral Meniscal Length r = 0.7040, r = 0.7209

Stone KR, Freyer A, Turek T, Walgenbach AW, Wadhwa S, Crues J. Meniscal sizing based on gender, height, and weight. Arthroscopy 2007;23-5:503-8

Meniscal Sizing Based on Gender, Height, and Weight

Page 14: Biologic Knee Replacement Presentation

The Three-Tunnel TechniqueReplacing the Meniscus

Stone KR, Walgenbach AW. “Meniscal Allografting: the Three-Tunnel Technique.” Arthroscopy – The Journal of Arthroscopic and Related Surgery. 2003, 19(4):426-30.

Page 15: Biologic Knee Replacement Presentation

The Three-Tunnel Technique

Movie

Page 16: Biologic Knee Replacement Presentation

Articular Cartilage Paste Graft Procedure

Step 1

Step 5Step 4

Step 3Step 2

Page 17: Biologic Knee Replacement Presentation

Meniscus Transplantation

• 173 patients since 1997

• Clinical Exam + Patient Reported Subjective Outcome (1, 2, 3, 5, 7, 10, 15+ yrs)

• IKDC

• WOMAC

• TEGNER

The Stone Clinic Experience

Page 18: Biologic Knee Replacement Presentation

Current Study:

Long-Term Survival of Concurrent Meniscus Allograft Transplantation

and Articular Cartilage Repair: A Prospective 12-Year Follow-Up Evaluation

Pre-Allograft Allograft in placeTransplantation

OB IV

Page 19: Biologic Knee Replacement Presentation

Study Design

Study Inclusion

• Irreparable injury of the meniscus

Or

• Loss of the meniscus

– More than 50%

• OB III/IV

• ROM ≥ 90°

Study Exclusion

• Rheumatoid Arthritis

• Tri-compartment arthritis

• Total loss of joint space

• Simultaneous med/lat meniscus allograft transplantation

Page 20: Biologic Knee Replacement Presentation

Patient Selection

• Young patients with cartilage loss and pain

• Older patients with cartilage loss and focal pain who want to remain athletic and delay or avoid a knee arthroplasty.

• “Doc, isn’t there a shock absorber you can put in my knee?”

Page 21: Biologic Knee Replacement Presentation

Surgical Technique• Medial Meniscus Allograft

Transplantation: Performed utilizing periosteum, but not bone blocks, at the meniscus horns.

• Lateral Meniscus Allograft Transplantation: Preformed by preserving the bony block between the horns and inserting it into a bone trough.

Page 22: Biologic Knee Replacement Presentation

• 119 Meniscus Allograft Transplant Cases

• Mean age = 46.9 years (14.1 – 73.2 yrs)

• Mean follow-up = 5.8 years (2.1 mo – 12.3 yrs)

• 118 patients ≥ 3 months from injury to time of surgery (Mean = 14.2 years)

Patient Population

Page 23: Biologic Knee Replacement Presentation

Patient Population (N = 119)

Neutral / Varus / Valgus

Moderate ( 5 – 7°) / Severe ( > 7°)

Grade III / Grade IV

Medial / Lateral

Male / Female

None / Mild–Moderate / Severe

(Kellgren-Lawrence)

Page 24: Biologic Knee Replacement Presentation

Review of Literature

Mixed Patient Studies

N = 119

N = 100

N = 29

N = 31

N = 44

Page 25: Biologic Knee Replacement Presentation

Results

• Procedure failure: Removal of allograft without revision (N = 7), or progression to knee arthroplasty [N = 18 (TKA or UNI)].

• 94/119 allograft cases successful (79%)– Of 25 failures, Mean time-to-failure:

4.65 ± 2.99 years

– Range: 2.1 months – 10.37 years

• Kaplan-Meier estimated mean survival time was 9.93 ± 0.40 years [95%CI: 9.14,10.72]

• 13 patients were lost to follow-up

Page 26: Biologic Knee Replacement Presentation

Complications

• 4 Early Postoperative Infections– 3 Deep (1 Staphphylococcus Aures, 2 negative

serologies)– 1 Superficial (Staphylococcus Epidemis)

• All cases were treated arthroscopically with irrigation and debridement and IV antibiotics.

• All cases resolved, but one deep infection case ultimately failed, with the allograft being removed 12.5 months later.

Page 27: Biologic Knee Replacement Presentation

Subsequent Surgeries

Primary Procedure

Subsequent Surgeries

1st

N = 62

2nd

N = 21

3rd

N = 10

4th

N = 2

Meniscus Allograft Revision 2 4 1 –Meniscus Allograft Repair 12 1 2 –Meniscectomy 22 9 1 –Microfracture /Articular Cartilage Paste Grafting 4 – 1 1

Chondroplasty / Debridement 20 6 4 1Other 2 1 1 –

Page 28: Biologic Knee Replacement Presentation

Kaplan-Meier Survival AnalysisIn Patients OB III/IV

• Time-to-failure analysis with continuous enrollment over 12-yrs

• Takes into account remaining patients (still intact / lost to follow-up (N=13))

Intact/Lost To Follow-Up

94%92% 84% 79% 67%

Page 29: Biologic Knee Replacement Presentation

Cox Proportional Hazards ModelWhat is it?

• A Cox model provides an estimate of a

variable’s effect on survival after

adjustment for other explanatory

variables.

• In addition, it allows us to estimate the

hazard (or risk) of procedure failure, given

their prognostic variables.

Page 30: Biologic Knee Replacement Presentation

What factors affect survival?• Cox Proportional Hazards Model was used

to explore the relationship between procedure failure and several covariates.

Age (p = 0.026)

Number of Previous Surgeries (p = 0.006)

Number of Additional Surgeries

Osteotomy performed concomitantly

Number of concomitant procedures

Outerbridge Grade (III or IV)

Medial v. Lateral Allograft

Joint Space Narrowing

Malalignment Severity

Alignment Type

Sex

NOT RELATEDRELATED

Page 31: Biologic Knee Replacement Presentation

Cox Model - Related Hazards

• Independent of actual time-to-failure, increased number of previous surgeries (p = 0.026) and increased age at time of surgery (p = 0.006) increases the risk of meniscus allograft transplantation failure.

Page 32: Biologic Knee Replacement Presentation

Effect of Age• 53 patients over 50 (Mean = 56 yrs)

– KM mean survival = 8.84 years [95% CI: 7.51,10.17]

– 71.7% (38/53) Success Rate1 allograft removed 2 mo. post-op

14 progressed to Joint Arthroplasty @ mean 5.1 years

• 66 patients under 50 (Mean = 39 yrs)– KM mean survival = 10.67 years [95% CI: 9.76,11.58]

– 84.8% (56/66) Success Rate6 allografts removed @ mean 4.0 years

4 Progressed to Joint Arthroplasty @ mean 5.2 years

Page 33: Biologic Knee Replacement Presentation

Medial v. Lateral Allografts

Non Significant Hazard (p = 0.848)

Medial

(N = 85)

KM mean survival: 9.91 ± 0.46 years

Lateral

(N = 34)

KM mean survival:

10.17 ± 0.78 years

Page 34: Biologic Knee Replacement Presentation

Malalignment

• Severity of Mal-Alignment (p = 0.535)

– Severe Malalignment (>7º) (N = 10)

– Moderate Malalignment (5 – 7º) (N = 39)

7 Osteotomies– 71.4% Success Rate (5/7)– 2 UNI

3 NO Osteotomy– 66.7% Success Rate (2/3)– 1 UNI

– 50% Success Rate (4/8)– 2 TKA, 1 UNI, 1 Removed

8 Osteotomies– 80.6% Success Rate (25/31)– 2 TKA, 2 UNI, 2 Removed

31 NO Osteotomy

Page 35: Biologic Knee Replacement Presentation

Subjective Outcome Scores• IKDC, WOMAC, and TEGNER

questionnaire follow-up schedule was preoperatively and at 2, 3, 5, 7, 10, 15 year post-op.

• Tegner Index was used to normalize return to activity across a diverse population*

*Rodkey et al. Comparison of the collagen meniscus implant with partial meniscectomy. A prospective randomized trial. J Bone Joint Surg Am 2008;90-7:1413-26.

Current Tegner activity score

Highest reported pre-injury score= Tegner Index Score

Page 36: Biologic Knee Replacement Presentation

Subjective Outcome Scores

1.00

0.90

0.80

0.70

0.60

0.50

0.40

0.30

0.20

0.10

0.00

Mean T

egner Index S

core

Page 37: Biologic Knee Replacement Presentation

Patient Example: BK

• 27 year old male• Torn lateral meniscus in high school wrestling 1996• Partial lateral meniscectomy 2/96, 8/04

Pre-Operative X-Rays

Page 38: Biologic Knee Replacement Presentation

BK: Pre-Op MRI

• MRI documents degenerative changes to LTP and loss of lateral meniscus

Page 39: Biologic Knee Replacement Presentation

Patient Example: BK

• Lateral Meniscus Allograft Transplantation

Page 40: Biologic Knee Replacement Presentation

Patient Example: BK 8 months post

• Arthroscopy for suprapatellar pouch and anterolateral swelling

• Lateral meniscus allograft transplant had healed

Page 41: Biologic Knee Replacement Presentation

BK MRI 4 Years Post Op

•Lateral meniscus allograft appears normal and well positioned

•Patient reports no pain - “It feels really good”

Page 42: Biologic Knee Replacement Presentation

Patient Example: JL

• 35 Year Old Female

Right Knee • 1984 - Lateral

Meniscectomy• 1988 - Lateral release• 2003 - Knee locked, total

meniscectomy• Valgus Alignment

Page 43: Biologic Knee Replacement Presentation

Patient Example: JL

OB III/IV far-posterior aspect LFC, Microfracture LFC

Page 44: Biologic Knee Replacement Presentation

JL: 4 months Post-Op

• Flexion contracture, debridement, closed manipulation, notchplasty

• No evidence of meniscal impingement

• Healed, intact lateral meniscus

Page 45: Biologic Knee Replacement Presentation

JL: 6 years Post-Op

• Lateral Meniscus repair, chondroplasty, debridement, notchplasty

Page 46: Biologic Knee Replacement Presentation

Patient Example: JA

• 37 Year old female

• Meniscectomy at age 20

• R-Lateral Meniscus missing

• OB III chondral defect

• Microfracture, Chondroplasty LFC

Long-Leg AP

Page 47: Biologic Knee Replacement Presentation

JA: Preoperative X-ray

LateralAP

Page 48: Biologic Knee Replacement Presentation

JA: Preoperative MRI

Lateral meniscus:• Absent posterior horn

Articular Cartilage:• Chondral damage

to LFC

Page 49: Biologic Knee Replacement Presentation

JA Operative Images

A B CDeficient Lateral

MeniscusChondral Lesion of

LFCMicrofracture of

Lesion

Page 50: Biologic Knee Replacement Presentation

JA Operative Images

A B CAbsent Meniscus Lateral Meniscus

AllograftAllograft

Placement

Page 51: Biologic Knee Replacement Presentation

JA: 5 Months Post-Op

Full ROM with smooth articulation

Page 52: Biologic Knee Replacement Presentation

JA: 2Yr Postoperative X-ray

PA Flexion AP

Page 53: Biologic Knee Replacement Presentation

JA: 2yr Post-operative MRI

• Healed lateral meniscal allograft

Page 54: Biologic Knee Replacement Presentation

JA: 5Yr Postoperative X-Ray

PA Flexion AP

Page 55: Biologic Knee Replacement Presentation

JA: 5Yr Postoperative MRI

• Virtually unchanged meniscal allograft

Page 56: Biologic Knee Replacement Presentation

Patient Example: GC

7o varus L-knee

Medial joint space narrowing

Active 53 y.o. male.

Meniscectomy: 1986, 1996

Medial meniscus-allograft 3/99

Paste Graft MFC & MTP

High medial tibial osteotomy (Bionx wedge and allograft bone)

Page 57: Biologic Knee Replacement Presentation

GC: Preoperative Images

Sagittal MRI

Loss of cartilage MFC

PA Flexion

Medial joint space narrowing

Page 58: Biologic Knee Replacement Presentation

GC: Operative Images

A BBipolar lesions Morselization of MFC & MTP

Loss of medial meniscus

Page 59: Biologic Knee Replacement Presentation

GC: Operative Images

A B CPlacement of medial

meniscal allograftImpaction ofpaste graft

Paste GraftedLesion

Page 60: Biologic Knee Replacement Presentation

GC: Postoperative X-Ray

Long-leg AP

Page 61: Biologic Knee Replacement Presentation

GC: 3Yr Postoperative X-ray

APLong-leg

Page 62: Biologic Knee Replacement Presentation

GC: 3Yr Postoperative Images

3 Years post-op L-medial allograft, osteotomy, & paste graft

Page 63: Biologic Knee Replacement Presentation

GC: Comparison of healing

3-Years post-op allograft and paste graft to MFC

Operative 3 yrs Post-op 3 yrs Post-op

Page 64: Biologic Knee Replacement Presentation

Patient Example: SC

• 39 y.o. male• Injury: 1970s playing hockey

• Meniscectomy (1999)

• Pre-op: • Varus • Joint space narrowing

• Right Medial Meniscus Allograft (2000)

Page 65: Biologic Knee Replacement Presentation

SC: Preoperative MRI

Bucket-handle tear with bipolar cartilage lesions on MFC & MTP

Coronal Sagittal

Page 66: Biologic Knee Replacement Presentation

SC: Operative Images

Right knee bucket-handle tear displaced into intercondylar notchA B

Page 67: Biologic Knee Replacement Presentation

Eburnated bone MFC Eburnated bone MTP

Microfracture MTP Microfracture MTP

SC: Operative Images

Page 68: Biologic Knee Replacement Presentation

SC: Placement of Allograft

Right Knee Placement of Medial Meniscal Allograft

Page 69: Biologic Knee Replacement Presentation

SC: Comparison of healing

Return to full activity

Intermittent catching and pain

17 Mo Post-opPre-op

Note improved joint space compared to pre-op

Page 70: Biologic Knee Replacement Presentation

SC: 17 Mo Post Op MRI

Coronal Sagittal

Page 71: Biologic Knee Replacement Presentation

SC: 2nd Surgery

Movie 17 mo. Post Paste graft MFC + Meniscus Allograft

Initial Surgery 17 mo. Post-opMeniscectomy

Page 72: Biologic Knee Replacement Presentation

SC: 5 yr Post Op Images

AP

Allograft present with maturing degenerative changes

Coronal

Page 73: Biologic Knee Replacement Presentation

Patient Example DB

• 47 YO Male Skier

• R Knee: Chronic Pain

• Moderate to Severe Bilateral Pain

Page 74: Biologic Knee Replacement Presentation

DB: Right Knee

Right Knee:

• 09/91: Medial Meniscectomy, Drilling MFC, Chondroplasty

• 12/97: (triple) Medial Meniscus Allograft, Osteotomy, Art Cart MFC, MFx LFC

• 05/98: Revision Osteotomy, Medial Meniscectomy, Debridement, MFx MTP

• 10/2000: Ilizarov, Meniscectomy, ChondroplastyPre-Op XRAY

Page 75: Biologic Knee Replacement Presentation

DB: Right Knee 10 Yr PostOp MRI

Page 76: Biologic Knee Replacement Presentation

DB: 10 Yr Post Op XRAY

Page 77: Biologic Knee Replacement Presentation

DB: 10 Yr PostOp

63 YO, Tegner = 6, Skis 30+ days/yr, Snow skis 50+ days/yr.

Page 78: Biologic Knee Replacement Presentation

• 47 YO Female

• Beach volleyball injury (11/03)

• Failed debridement (11/03)

• Clinical exam:– Pain at rest = 8/10– Severe swelling – Giving way

• Meniscus Allograft, ACL reconstruction, Chondroplasty (3/05)

Patient Example: RT

Page 79: Biologic Knee Replacement Presentation

RT: Pre-Operative MRI

Page 80: Biologic Knee Replacement Presentation

Torn medial meniscus

MFC chondral lesion

LFC chondral lesion Torn ACL

Patient Example: RT

Page 81: Biologic Knee Replacement Presentation

Medial meniscus Allograft Allograft Insertion

Allograft placement ACL BTB allograft

Patient Example: RT

Page 82: Biologic Knee Replacement Presentation

• Intact meniscus allograft• ACL hardware removal due to prominence of fixation screw

RT: 3 Months Post

Page 83: Biologic Knee Replacement Presentation

Excellent joint space, intact meniscus allograft and ACL, but right knee clicking and catching

RT: 18 Months Post

Page 84: Biologic Knee Replacement Presentation

Intact meniscus allograft and ACL with diffuse thinning of patellofemoral cartilage

RT: 18 Months Post

Page 85: Biologic Knee Replacement Presentation

• Surgery for catching due to chondral flap at patellofemoral joint

• Intact meniscus allograft and ACL

RT: 18 Months Post

Page 86: Biologic Knee Replacement Presentation

Patient Example: RM57 Male

Long-leg MRI

• Injury: Football tackle 1978 • Previous Meniscectomy: 1978, 1993• Moderate varus mal alignment (≤ 7°)• MFC OCD lesion

Page 87: Biologic Knee Replacement Presentation

RM: Operative Images

Severe Articular Cartilage Damage

Page 88: Biologic Knee Replacement Presentation

RM: Operative Images

Allograft insertionArticular Cartilage

Paste Grafting Repair

Page 89: Biologic Knee Replacement Presentation

RM: Operative Images

High tibial opening wedge osteotomy

Page 90: Biologic Knee Replacement Presentation

RM: 3.5 Years Post-Allograft

Movie

Primary Surgery Second Look, 3.5 years later

Page 91: Biologic Knee Replacement Presentation

RM: Histology

Page 92: Biologic Knee Replacement Presentation

RM: 3.5 Years Post Operative

Long-leg

Page 93: Biologic Knee Replacement Presentation

RM: 5 Years Post Operative MRI

SagittalCoronal

Page 94: Biologic Knee Replacement Presentation

RM: 6 Year Post Operative X-Ray

Long-leg

Lateral

Page 95: Biologic Knee Replacement Presentation

Patient Example: HM

5-7o varus L-knee

• 18 Yrs Post meniscectomy

• 2 Meniscectomies (‘86, ’96)

• Pain >1 year

• Varus deformity

• Medial joint space narrowing

• L-medial meniscus-allograft (3/1999)

• Paste graft MFC & MTP

• High medial tibial osteotomy (Bionx wedge and allograft bone)

• Chondroplasty LFC

• Partial lateral meniscectomy

• Notchplasty

Page 96: Biologic Knee Replacement Presentation

HM

4 Yrs 9 Mo Post Paste Graft

Debrided lesion Healed paste graft

Page 97: Biologic Knee Replacement Presentation

HM

4 Yrs 9 Mo Post Paste Graft

Biopsy Histology

Page 98: Biologic Knee Replacement Presentation

Biologic Knee Replacement Revision Surgery

Page 99: Biologic Knee Replacement Presentation

Patient Example: TA• 48 y.o. world-class female marathoner

• 86 marathons, • 12 Ironmans• 3 Double Ironman Triathalons

• Neutral alignment / mild medial joint space narrowing

• Meniscectomy: 4/2001 and 1/2002

AP X-ray

•R Medial Meniscus Allograft + Microfracture (bipolar lesions)

Page 100: Biologic Knee Replacement Presentation

TA: Preoperative MRI

• Tear at horn of medial meniscus• Osteoarthritis: medial compartment

SaggitalCoronal

Page 101: Biologic Knee Replacement Presentation

4/22/02: Right medial meniscus rim before allograft

TA: Operative Images

Page 102: Biologic Knee Replacement Presentation

TA: Meniscus Allograft Placement

A B MoviePreparation of medial

meniscal allograftPlacement of medial

meniscal allograftRelationship of lesion

to meniscus

Page 103: Biologic Knee Replacement Presentation

TA: Injury

C

• Injury: 2 Mo. Post-op

• Swam in pool for 2 hours

• Developed immediate swelling

A Movie

Page 104: Biologic Knee Replacement Presentation

TA: Revision

CA

Movie

Revision: 8 Months Post-allograft

Page 105: Biologic Knee Replacement Presentation

TA: Revision: Operative Images

Insertion of Meniscus Allograft with Articular Cartilage Paste Grafting

Joint Arthroplasty 3/2006 (38 Mo. Post Op)

A B C

D

Page 106: Biologic Knee Replacement Presentation

Patient Example: RT

• 34 YO male

• Partial meniscectomy for torn lateral meniscus (9/91), debridement 2006

• Lateral joint line pain

• Severe pain and swelling with activities

• Positive Apley’s, McMurray’s, and hyperextension tests

Page 107: Biologic Knee Replacement Presentation

RT: Pre-Op Imaging

• X-rays: Collapse of lateral joint space. Mild patellar spurring.

Page 108: Biologic Knee Replacement Presentation

RT: Pre-Op MRI

• Loss of articular cartilage on posterior aspect of LFC• Loss of posterior and central aspects of lateral meniscus

PD SAG PD COR

Page 109: Biologic Knee Replacement Presentation

RT: Surgery 11/2009

• Lateral Meniscus Allograft transplantation

• Microfracture LFC and LTP (too far posterior for Articular Cartilage Paste Grafting)

• Removal of anvil osteophyte

Page 110: Biologic Knee Replacement Presentation

RT: MRI 2 days Post Op

• Allograft intact without evidence of tear• Anterior subluxation of the posterior aspect of the

lateral meniscus with anterior displacement of the bone block (12 mm).

FSE T2 SAG FSE PD SAG

Page 111: Biologic Knee Replacement Presentation

RT: Revision Surgery

• Interval repositioning of the lateralmeniscus 5 days post index procedure.

• Re-microfracture of distal femoral condyleto ensure good blood clot.

Page 112: Biologic Knee Replacement Presentation

RT: MRI 1 Day Post Revision

• Repositioned Lateral Meniscus Allograft

FSE T2 SAG FSE PD SAG

Page 113: Biologic Knee Replacement Presentation

Conclusions• Our research represents the largest and

longest prospective study of meniscus replacement patients with severe chondral damage.

• Meniscus replacement can improve symptoms, even in severe OA.

• Meniscus replacement should not be limited to young patients without articular cartilage damage.

• Axial malalignment does not affect outcome.

Page 114: Biologic Knee Replacement Presentation

Conclusions

• Height and weight can be used to size meniscal allograft tissue.

• Three-tunnel Technique is necessary to fix meniscus allograft to tibial plateau, not the surrounding tissue, to avoid meniscus subluxation

Page 115: Biologic Knee Replacement Presentation

Conclusions

• Repair of severe articular cartilage damage combined with meniscus replacement provides significant improvements in activity, pain, and function.

• Improvements are maintained over the course of follow-up (2 – 12 yrs).

Page 116: Biologic Knee Replacement Presentation

Conclusions • The number of TKA surgeries is predicted to

increase to 3.4 million by 2030*, with increasing costs†.

• 18/119(15%) cases in our study progressed to knee arthroplasty 4.8 years after meniscus replacement (range: 1.3 – 10.4 yrs).

• Average age at time of knee arthroplasty was 61 years (range: 52 – 72 yrs).

*Kurtz, AAOS Chicago, 2006†Kurtz, JBJS, 2007

Page 117: Biologic Knee Replacement Presentation

Conclusions

• Biologic joint reconstruction, rather than bionic (artificial) replacement, may be an appropriate first step for many people with knee joint arthritis.

Page 118: Biologic Knee Replacement Presentation

Acknowledgements

• Thomas Turek

• Mark Coleman

• Abhi Freyer

• Ann Walgenbach

• Jonathan Pelsis

• Wendy Adelson

• Sharon Bobrow

Meniscus Allograft Transplantation: 1997 – 2010

Articular Cartilage Paste Grafting: 1991 – 2010

Page 119: Biologic Knee Replacement Presentation

2009 Team

2005 Team